In breast cancer cells, sirtuin-5 (SIRT5), a mitochondrial NAD+-dependent lysine deacylase, was shown to stabilize GLS by desuccinylating GLS and preventing it from ubiquitin-mediated degradation [169]. Here, SIRT5 is linked to breast carcinoma.